HOPHF
Price:
$2.33
Market Cap:
$56.13M
Hemogenyx Pharmaceuticals Plc is a preclinical-stage biotechnology firm dedicated to discovering, developing, and bringing to market innovative therapies for various blood-related diseases. The company's pipeline includes several promising candidates tailored for the bone marrow/hematopoietic stem cell (BM/HSC) transplant market. These include a CDX bi-specific antibody designed to target relapsed/refractory acute myeloid leukemia (R/R AML), certain forms of acute lymphoblastic leukemia, and myelodysplastic syndrome. This novel approach seeks to condition patients for bone marrow transplants, offering a potential alternative to conventional chemotherapy and/or radiation treatments. Additiona...[Read more]
Industry
Biotechnology
IPO Date
2021-01-12
Stock Exchange
OTC
Ticker
HOPHF
According to Hemogenyx Pharmaceuticals Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 56.55M. This represents a change of 198.15% compared to the average of 18.97M of the last 4 quarters.
The mean historical Enterprise Value of Hemogenyx Pharmaceuticals Plc over the last ten years is 549.01M. The current 56.55M Enterprise Value has changed 930.06% with respect to the historical average. Over the past ten years (40 quarters), HOPHF's Enterprise Value was at its highest in in the June 2017 quarter at 3.43B. The Enterprise Value was at its lowest in in the August 2014 quarter at 0.
Average
549.01M
Median
14.88M
Minimum
4.63M
Maximum
5.34B
Discovering the peaks and valleys of Hemogenyx Pharmaceuticals Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 447.26%
Maximum Annual Enterprise Value = 5.34B
Minimum Annual Increase = -99.91%
Minimum Annual Enterprise Value = 4.63M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 25.83M | 63.12% |
| 2024 | 15.83M | -42.77% |
| 2023 | 27.67M | 98.76% |
| 2022 | 13.92M | 80.33% |
| 2021 | 7.72M | -80.63% |
| 2020 | 39.85M | 411.35% |
| 2019 | 7.79M | 11.75% |
| 2018 | 6.97M | 50.60% |
| 2017 | 4.63M | -99.91% |
| 2016 | 5.34B | 447.26% |
The current Enterprise Value of Hemogenyx Pharmaceuticals Plc (HOPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
23.11M
5-year avg
18.19M
10-year avg
549.01M
Hemogenyx Pharmaceuticals Plc’s Enterprise Value is greater than Kiromic BioPharma, Inc. (13.65M), less than TuHURA Biosciences, Inc. (141.90M), greater than Vitalibis, Inc. (1.32M), greater than Advanced Proteome Therapeutics Corporation (-63027.00), greater than CuraScientific Corp (3.01M), greater than Evome Medical Technologies Inc. (19.72M), greater than ProSomnus, Inc. (42.48M), less than Pivotal Therapeutics Inc. (0), greater than TRACON Pharmaceuticals, Inc. (-7486275.00), greater than Predictive Technology Group, Inc. (7.51M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 13.65M | $214.93K | |
| 141.90M | $147.74M | |
| 1.32M | $227.44K | |
| -63027.00 | $149.63K | |
| 3.01M | $377.35K | |
| 19.72M | $5.98K | |
| 42.48M | $8.18M | |
| 0 | $172.43K | |
| -7486275.00 | $109.72K | |
| 7.51M | $89.88K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemogenyx Pharmaceuticals Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemogenyx Pharmaceuticals Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hemogenyx Pharmaceuticals Plc's Enterprise Value?
What is the highest Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?
What is the 3-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?
What is the 5-year average Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF)?
How does the current Enterprise Value for Hemogenyx Pharmaceuticals Plc (HOPHF) compare to its historical average?